Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
Cherokee Nation Public Health, Cherokee Nation, Tahlequah, OK, 74464, USA.
Cancer Causes Control. 2023 Mar;34(3):267-275. doi: 10.1007/s10552-022-01662-y. Epub 2022 Dec 21.
We estimated human papillomavirus (HPV) vaccine initiation coverage among American Indian adolescents and identified factors associated with HPV vaccination among parents of these adolescents.
We developed, tested, and disseminated a survey to a random sample of 2,000 parents of American Indian adolescents aged 9-17 years who had accessed Cherokee Nation Health Services from January 2019 to August 2020. We used log-binomial regression to estimate the unadjusted and adjusted weighted prevalence proportion ratios (PPR) and 95% confidence intervals (CI) for adolescent HPV vaccine initiation.
HPV vaccine initiation coverage (≥ 1 dose) was 70.7% among adolescents aged 13-17 years. The prevalence of HPV vaccine initiation was higher among American Indian adolescents whose parents were aware of the HPV vaccine (adjusted weighted PPR 3.41; 95% CI 2.80, 4.15) and whose parents received a recommendation from their provider (adjusted weighted PPR 2.70; 95% CI 2.56, 2.84). The most common reasons reported by parents to vaccinate their children were to protect them against HPV-associated cancers (25.7%) and receiving a recommendation from a healthcare provider (25.0%). Parents cited vaccine safety concerns as the main reason for not getting their children vaccinated (33.2%).
HPV vaccine initiation coverage among American Indian adolescents in Cherokee Nation was consistent with the national survey estimates. However, allaying parental concerns about vaccine safety and encouraging providers to recommend the HPV vaccine could improve coverage.
我们评估了美国印第安青少年中人类乳头瘤病毒(HPV)疫苗接种的初始覆盖率,并确定了这些青少年父母中与 HPV 疫苗接种相关的因素。
我们针对 2000 名曾在 2019 年 1 月至 2020 年 8 月期间使用切罗基族国家卫生服务的 9-17 岁美国印第安青少年的父母,开发、测试并传播了一项调查。我们使用对数二项式回归来估计青少年 HPV 疫苗接种初始接种的未调整和调整后的加权流行率比例(PPR)和 95%置信区间(CI)。
13-17 岁青少年的 HPV 疫苗接种初始接种率(≥1 剂)为 70.7%。父母了解 HPV 疫苗(调整后的加权 PPR 3.41;95%CI 2.80,4.15)和父母从提供者那里获得推荐(调整后的加权 PPR 2.70;95%CI 2.56,2.84)的美国印第安青少年中,HPV 疫苗接种初始接种率较高。父母报告为孩子接种疫苗的最常见原因是预防 HPV 相关癌症(25.7%)和接受医疗保健提供者的推荐(25.0%)。父母表示,疫苗安全性担忧是他们不让孩子接种疫苗的主要原因(33.2%)。
在切罗基族国家,美国印第安青少年的 HPV 疫苗接种初始接种率与全国调查估计值一致。然而,减轻父母对疫苗安全性的担忧并鼓励提供者推荐 HPV 疫苗,可以提高接种率。